By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A new European Union-funded research consortium led by the Max Planck Society in Germany will use genomic and physiological data to create computational models of individual patients for use in personalized medicine applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.